Tovinontrine
Product Specifications
CAS Number
2062661-53-2
Target
PDE
Related Pathways
Metabolism
Purity
0.988
Bioactivity
Tovinontrine (IMR-687) (IMR-687) is a potent and selective inhibitor of phosphodiesterase-9 (PDE9), designed to target sickle cell disease treatment. It exhibits high efficacy, with IC 50 values of 8.19 nM and 9.99 nM for PDE9A1 and PDE9A2, respectively [1].
Smiles
C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1cn2c(ncc2c(=O)[nH]1)C1CCOCC1
Molecular Formula
C21H26N6O2
Molecular Weight
394.47
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6204067-01 0.1 mL
Vascular Endothelial Growth Factor A (VEGFA, VEGF-A, VEGF, Vascular Permeability Factor, VPF, MVCD1) (MaxLight 490)
Sign In for Pricing
View Details 
MBS6204067-02 5x 0.1 mL
Vascular Endothelial Growth Factor A (VEGFA, VEGF-A, VEGF, Vascular Permeability Factor, VPF, MVCD1) (MaxLight 490)
Sign In for Pricing
View Details 
TP306455 20 µg
Pyruvate Kinase (PKLR) (NM_000298) Human Recombinant Protein
Sign In for Pricing
View Details 
MBS6503410-01 0.2 mL
TGFBR1, ID (TGF-beta Receptor Type I, TGFR-1, Transforming Growth Factor-beta Receptor Type I, TGF-beta Type I Receptor, TbetaR-I, TGF-beta Type I Receptor, Serine/Threonine-protein Kinase Receptor R4, SKR4, Activin Receptor-like Kinase 5, ALK-5, TGF beta
Sign In for Pricing
View Details MBS6503410-02 5x 0.2 mL
TGFBR1, ID (TGF-beta Receptor Type I, TGFR-1, Transforming Growth Factor-beta Receptor Type I, TGF-beta Type I Receptor, TbetaR-I, TGF-beta Type I Receptor, Serine/Threonine-protein Kinase Receptor R4, SKR4, Activin Receptor-like Kinase 5, ALK-5, TGF beta
Sign In for Pricing
View Details